ARIDIS PHARMACEUTICALS INC (ARDS) Stock News

NASDAQ:ARDS - US0403341045 - Common Stock

0.3101 USD

+0.05 (+17.91%)

Last: 7/18/2023, 8:14:23 PM

0.2619 USD

-0.05 (-15.54%)

After Hours: 7/18/2023, 8:14:23 PM

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

ARDS Latest News, Press Relases and Analysis

All

Press Releases

8 months ago - By: Aridis Pharmaceuticals, Inc.

Aridis Provides Corporate Update

a year ago - By: Aridis Pharmaceuticals, Inc.

Aridis Provides Corporate Update

2 years ago - By: Aridis Pharmaceuticals, Inc.

Aridis Pharmaceuticals Announces Adjournment of Annual Meeting of Stockholders until January 12, 2024

2 years ago - By: Aridis Pharmaceuticals, Inc.

Aridis Pharmaceuticals Announces Third Quarter 2023 Financial Results and Business Update

2 years ago - By: Benzinga - Mentions: IVA TTOO MRKR PHIO ...

12 Health Care Stocks Moving In Wednesday's Intraday Session

2 years ago - By: Benzinga - Mentions: AKBA BLCM TENX VTGN ...

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

2 years ago - By: Aridis Pharmaceuticals, Inc.

Aridis Pharmaceuticals Announces $2 Million Offering

2 years ago - By: InvestorPlace - Mentions: BPTS KPTI SCLX NN ...

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

2 years ago - By: Aridis Pharmaceuticals, Inc.

Aridis Receives Agreement from the European Medicines Agency (EMA) on the Clinical Study Design and a Single Confirmatory Phase 3 Study of AR-301

2 years ago - By: Aridis Pharmaceuticals, Inc.

Aridis’ AR-301 Monoclonal Antibody is Among the First Biologics to Receive FDA’s Qualified Infectious Diseases Product (QIDP) Designation

2 years ago - By: Aridis Pharmaceuticals, Inc.

Aridis Pharmaceuticals Announces First Quarter 2023 Financial Results and Business Update

2 years ago - By: InvestorPlace - Mentions: TTOO MIMO AGBA FBIO ...

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

2 years ago - By: Aridis Pharmaceuticals, Inc.

Aridis Pharmaceuticals Receives Nasdaq Notice on Late Filing of its Form 10-Q

2 years ago - By: Aridis Pharmaceuticals, Inc.

Aridis Pharmaceuticals Receives Nasdaq Notice on Late Filing of its Form 10-K